Page 1,550«..1020..1,5491,5501,5511,552..1,5601,570..»

Molecular Cardiology Research Lab – Texas Heart Institute

Posted: Published on April 15th, 2018

Texas Heart Institutes Molecular Cardiology Research Laboratory (MCRL) is a unique team of researchers and scientists dedicated to leveraging their expertise in small molecule therapeutics to develop novel techniques to diagnose, treat and prevent cardiovascular disease. Small molecule therapeutics can be applied to various diagnostic and treatment practices used today to enhance how medical practitioners identify and treat patients suffering from heart disease and injury. Specifically, the MCRL team is focused on how applications can help to develop non-invasive imaging techniques to identify atherosclerotic plaques that may rupture or erode and cause heart attack or stroke, as well as applications that will help improve adult stem cell therapies. Their work in the stem cell arena ranges from ways to enhance the efficacy of stem cell therapies to treat heart failure to improvements in stem cell mobilization that will make bone marrow transplants more effective. Additionally, the team is researching the possibility of genetically modified stem cells to treat pulmonary hypertension and peripheral vascular disease, among other indications. Led by esteemed scientist Richard Dixon, PhD, the departments translational research has led to the successful patenting and licensing of new technologies that are not only applicable to enhancing cardiovascular treatments and therapies, … Continue reading

Posted in Molecular Cardiology | Comments Off on Molecular Cardiology Research Lab – Texas Heart Institute

Duchenne Muscular Dystrophy: Causes, Symptoms, Treatment …

Posted: Published on April 14th, 2018

Duchenne muscular dystrophy (DMD) is one of the most common and devastating types of muscular degeneration and results in progressive muscle weakness, starting at young age.1,2 A genetic disorder, DMD primarily affects boys and is characterized by loss of the protein dystrophin in muscle cells as a result of genetic mutations.3,4 The associated cell damage and uncontrolled influx of calcium leads to mitochondrial dysfunction and reduced energy production in muscle cells.5 This contributes to progressive muscle weakness and loss of muscle tissue over time including a decline in pulmonary function leading to trouble breathing.4,5 The average age at which boys will start to show symptoms of DMD is 3 to 5 years, and they are commonly unable to walk by their teenage years.1,4,6 As the disease progresses, the muscles affected include those needed for breathing (respiration),causing a problem called respiratory insufficiency that leads to worsening breathing.This means that patients with DMD suffer from a decline in respiratory function, may need support to breathe and may have more frequent lung infections.79 Other typical symptoms include a weak cough, chest infections, daytime sleepiness, headaches, suffering from nightmares, or other respiratory and pulmonary infections. See more here: Duchenne Muscular Dystrophy: Causes, Symptoms, Treatment … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Duchenne Muscular Dystrophy: Causes, Symptoms, Treatment …

Parkinson Disease Treatment & Management: Approach Considerations, Symptomatic …

Posted: Published on April 14th, 2018

Hauser RA, Grosset DG. [(123) I]FP-CIT (DaTscan) SPECT Brain Imaging in Patients with Suspected Parkinsonian Syndromes. J Neuroimaging. 2011 Mar 16. [Medline]. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011 Jun. 26 Suppl 1:S1-58. [Medline]. Anderson P. More Evidence Links Pesticides, Solvents, With Parkinson's. Medscape Medical News. Available at http://www.medscape.com/viewarticle/804834. Accessed: June 11, 2013. Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. 2013 May 28. 80(22):2035-41. [Medline]. Liu R, Guo X, Park Y, Huang X, Sinha R, Freedman ND, et al. Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women. Am J Epidemiol. 2012 Apr 13. [Medline]. Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology. 1985 Jul. 35(7):949-56. [Medline]. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, et al. Parkinson disease in twins: an etiologic study. JAMA. 1999 Jan 27. 281(4):341-6. [Medline]. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997 Jun 27. … Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson Disease Treatment & Management: Approach Considerations, Symptomatic …

Managing Right Ventricular Failure in PAH: An Algorithmic …

Posted: Published on April 14th, 2018

Vol 4, No 4 (Winter 2005) Pulmonary arterial hypertension (PAH) is a disorder characterized by progressive elevation of pulmonary artery pressure (PAP) and vascular resistance in the absence of left-sided cardiac disease, pulmonary vein compression, respiratory disorders, or thromboembolic disease. It is defined by a mean PAP over 25 mmHg at rest or over 30 mmHg with exercise and a pulmonary artery occlusion pressure (PAOP) of less than 15 mmHg. PAH is associated with a poor prognosis. The estimated median survival from diagnosis is 2.8 years and the 1-year and 5-year survival rates are only 68% and 34%, respectively.1 2 More than 70% of PAH patients will die as a result of right ventricular failure and most of the remainder from dysrhythmia. Predictors of a poor prognosis in PAH are related to the development of right ventricular failure.3 4 5 The objectives of this review are to examine the pathophysiologic mechanisms leading to the development of right ventricular failure due to PAH, the diagnostic features of right ventricular failure, and the management of chronic right ventricular failure with emphasis on acute decompensation in this setting. Clinical Manifestations and Hemodynamic DerangementsThe normal right ventricle is a thin-walled (less than 0.6 cm), … Continue reading

Posted in ALS Treatment | Comments Off on Managing Right Ventricular Failure in PAH: An Algorithmic …

Cardiology | Weill Cornell Medicine

Posted: Published on April 14th, 2018

Peripheral arterial disease affects almost 10 million patients, yet it remains one of the most underdiagnosed and undertreated conditions. In some patients clogged arteries are not limited just to the heart. Cholesterol plaques can affect the arteries of the neck (carotid arteries), kidneys (renal arteries), aorta, and arteries of the legs and arms. Peripheral arteral disease can result in leg or arm discomfort while exercising, leg ulcers and other serious complications. Our team of specialists includes experts in both diagnostic imaging and endovascular procedures who are specially trained to detect abnormalities in the vascular/circulation system and who focus specifically on detection and treatment of peripheral arterial disease. These vascular specialists are board certified in vascular or endovascular medicine, cardiovascular disease, and interventional cardiology and are fellowship trained with additional specialization in vascular procedures. Noninvasive Vascular Imaging To accurately diagnose abnormalities in the vascular system, our specialists rely on noninvasive tests that use cuffs similar to those used to measure arm blood pressure and ultrasound technology (seeVascular Imagingsection). These tests can be conveniently performed at the same location and during a regular office visit and include: Other diagnostic tests and techniques include A Multidisciplinary Approach To Peripheral Artery Disease The Endovascular … Continue reading

Posted in Clinical Cardiology | Comments Off on Cardiology | Weill Cornell Medicine

Managing Right Ventricular Failure in PAH: An Algorithmic Approach | Advances in …

Posted: Published on April 13th, 2018

Vol 4, No 4 (Winter 2005) Pulmonary arterial hypertension (PAH) is a disorder characterized by progressive elevation of pulmonary artery pressure (PAP) and vascular resistance in the absence of left-sided cardiac disease, pulmonary vein compression, respiratory disorders, or thromboembolic disease. It is defined by a mean PAP over 25 mmHg at rest or over 30 mmHg with exercise and a pulmonary artery occlusion pressure (PAOP) of less than 15 mmHg. PAH is associated with a poor prognosis. The estimated median survival from diagnosis is 2.8 years and the 1-year and 5-year survival rates are only 68% and 34%, respectively.1 2 More than 70% of PAH patients will die as a result of right ventricular failure and most of the remainder from dysrhythmia. Predictors of a poor prognosis in PAH are related to the development of right ventricular failure.3 4 5 The objectives of this review are to examine the pathophysiologic mechanisms leading to the development of right ventricular failure due to PAH, the diagnostic features of right ventricular failure, and the management of chronic right ventricular failure with emphasis on acute decompensation in this setting. Clinical Manifestations and Hemodynamic DerangementsThe normal right ventricle is a thin-walled (less than 0.6 cm), … Continue reading

Posted in Ventricular Remodeling | Comments Off on Managing Right Ventricular Failure in PAH: An Algorithmic Approach | Advances in …

Types of Cerebral Palsy | Forms of CP | CerebralPalsy.orgCerebralPalsy.org

Posted: Published on April 13th, 2018

Several Cerebral Palsy classification systems exist today to define the type and form of Cerebral Palsy an individual has. The classification is complicated by the wide range of clinical presentations and degrees of activity limitation that exist. Knowing the severity, location and type of Cerebral Palsy your child has will help to coordinate care and fund treatment. What type of Cerebral Palsy does my child have? And, why does one doctor classify my childs Cerebral Palsy one way, while the other doctor labels it another way? Professionals who specialize in the treatment of Cerebral Palsy approach the condition from a number of different vantage points. An orthopedic surgeon requires a definition of the limbs affected and the extent of impairment in order to prescribe treatment. Neurosurgeons and neuroradiologists, on the other hand, are more concerned with the cause of the brain damage and descriptors for imposing white and gray matter so as to determine the type of brain injury or brain malformation. They are also concerned with diagnosing the extent and severity level of the childs Cerebral Palsy. At first, a parent may be concerned with the severity level classification mild, moderate or severe in order to better understand the … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Types of Cerebral Palsy | Forms of CP | CerebralPalsy.orgCerebralPalsy.org

Medical Management – Duchenne Muscular Dystrophy (DMD)

Posted: Published on April 13th, 2018

Thanks to advances in many areas of medicine, such as cardiology and pulmonology, people with Duchenne muscular dystrophy in the 21st century are living longer than in previous decades, often well into adulthood. The use of available treatments can help maintain comfort and function and prolong life. Talk with anMDA clinicphysician for more information. People with DMD may haveunexpected adverse reactions to certain types of anesthesia. It's important that the surgical team know about the patient's DMD so that complications can be avoided or quickly treated. Braces, also calledorthoses, support the ankle and foot, or may extend up over the knee.Ankle-foot orthoses (AFOs) are sometimes prescribed for night wear to keep the foot from pointing downward and keep the Achilles tendon stretched while the child is sleeping. Standing for a few hours each day, even with minimal weight bearing, promotes better circulation, healthier bones and a straight spine. Astanding walker or standing framecan assist people with DMD to stand. Some wheelchairs will raise the user into a standing position. Sooner or later, a wheelchair is needed in DMD, typically by about age 12. Unless there's an injury, such as a broken leg, wheelchair use usually is gradual. Many at first … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Medical Management – Duchenne Muscular Dystrophy (DMD)

Cardiac Nursing Nursing Schools – RNtoMSN – Find Top Masters in Nursing Programs …

Posted: Published on April 13th, 2018

Cardiac Nursing Education and Curriculum There are several Masters in nursing programs for cardio-vascular nurses across the country, most commonly allowing you to incorporate cardiac courses into a Clinical Nurse Specialist or Nurse Practitioner role. While the CNS role is most common, there are several ways to specialize within this field. Many nursing schools across the country offer a Clinical Nurse Specialist Master's degree program. These programs are designed to prepare students who want to expand their expertise related to the management of a specific patient population, including Cardiac Care nursing. Eligibility for admission criteria usually includes: Undergraduate Statistics and Health Assessment are required prerequisites. The curriculum for a typical Clinical Nurse Specialist program includes: The advanced practice nursing coursework prepares you through clinical courses that include cardiovascular disease, risk assessment, health assessment, cardiac abnormalities and differential diagnosis of cardiovascular conditions. Some nursing schools have Clinical Nurse Specialist MSN programs which are delivered in an online format. You are usually required to attend one orientation day on campus when the program starts, and the clinical portion is intended to be completed in your local region. There are also RN to MSN programs to become a CNS, and you may have … Continue reading

Posted in Cardiac Nursing | Comments Off on Cardiac Nursing Nursing Schools – RNtoMSN – Find Top Masters in Nursing Programs …

Vascular Cell and Molecular Biology | Center for Vascular Biology | Weill Cornell …

Posted: Published on April 13th, 2018

Retinal blood vessels (green) from a mouse with retinal disease which models diabetic retinopathy. Vascular biologists at Weill Cornell study the basic workings of the vascular cells by using modern cellular and molecular biology methods. Proteins, lipids, mRNAs from vascular cells are analyzed in the laboratory to gain new knowledge into the inner workings of the vascular system. Such knowledge can be applied in whole organismal systems, such as Zebrafish and murine models as well as translational studies. Director, Center for Vascular BiologyDepartment of Pathology and Laboratory MedicineEmail: tih2002@med.cornell.eduPhone: 212-746-9953 Brine Family Professor and ChairDepartment of Cell and Developmental BiologyEmail: khajjar@med.cornell.eduPhone: 212-746-2034 Investigator, Howard Hughes Medical InstituteArthur Belfer Professor of Genetic MedicineDirector: Ansary Stem Cell Center for Regenerative MedicineDepartment of Genetic MedicineDivision of Vascular Hematology-OncologyEmail: srafii@med.cornell.eduPhone: 212-746-2286 Professor in the Department on MedicineProfessor in the Department of Physiology & BiophysicsEmail: cpb2002@med.cornell.edu Professor of BiochemistryVladimir Horowitz and Wanda Toscanini Horowitz Distinguished Professor of NeuroscienceChairman of BiochemistryEmail: frmaxfie@med.cornell.eduPhone: 212-746-6405 Professor and Vice Chair for Research, Department of SurgeryProfessor, Department of Cell and Developmental BiologyEmail: tre2003@med.cornell.eduPhone: 212 746-9485 Assistant Professor of Pathology and Laboratory MedicineEmail: and2039@med.cornell.eduPhone: 212 746-6476 Read more: Vascular Cell and Molecular Biology | Center for Vascular Biology | Weill Cornell … Continue reading

Posted in Vascular Biology | Comments Off on Vascular Cell and Molecular Biology | Center for Vascular Biology | Weill Cornell …

Page 1,550«..1020..1,5491,5501,5511,552..1,5601,570..»